
Ollin Biosciences
Clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
About
Ollin Biosciences, Inc. is a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
Where Ollin Biosciences is heading
Updated Nov 16, 2026, from 7 sources
Ollin Biosciences is a clinical-stage company developing OLN324, a treatment for diabetic macular edema and wet age-related macular degeneration.ollin.bio Its 2026 record shows head-to-head data against Vabysmo, a $330 million Series B, presentations at two major retina conferences, and an acquisition announced in November 2026.
ollin.bio
Mar 2026
Published final data from a randomized head-to-head study of OLN324 against faricimab (Vabysmo) in wet AMD and diabetic macular edema.
ollin.bio
Jun 2026
Raised an oversubscribed $330 million Series B to advance global Phase 3 development of OLN324 in DME and wet AMD, with studies starting in the second half of 2026.
ollin.bio
Jul 2026
Presented OLN324 data in diabetic macular edema and wet AMD at the American Society of Retina Specialists 44th Annual Scientific Meeting.
ollin.bio
Sep 2026
Presented at EURETINA 2026.
ollin.bio
Nov 2026
Announced acquisition of the company and its next-generation medicines for vision-threatening eye diseases.
ollin.bio
What it points to: Its head-to-head data against Vabysmo, an oversubscribed $330 million Phase 3 financing, and acquisition announcement point to OLN324 having built enough clinical momentum to attract a strategic buyer.ollin.bio
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Ollin Biosciences?
People comparing tools land here. Get listed beside these.
All funding rounds
Key facts
- Website
- ollin.bio
- Business model
- B2B
Tech stack
Detected on ollin.bio, last scanned 16 Nov 2026. Run your own scan
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Benchmarking
See how your site ranks against 16,849 startups
Ollin Biosciences sits in the 17th percentile for Domain Rating. Check where yours lands, free.
Check your Domain RatingOllin Biosciences has a Domain Rating of 10, the 17th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursEffective DR
Bottom 25%
Check yoursAgent Readiness
Top 25%
Scan yoursSite Speed
Above median
PageSpeedSecurity
Click to scan
Agent Readiness
Can AI agents use your site?
Ollin Biosciences scores 51. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Ollin Biosciences changes
Used Ollin Biosciences? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Are there companies like Ollin Biosciences?
Yes. We list 7 companies like Ollin Biosciences, including Apellis Pharmaceuticals, Infinimmune and LifeMine Therapeutics Inc..
SEC filings, insider activity, nonprofit links and pay benchmarks for Ollin Biosciences:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Ollin Biosciences and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


